Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Heijman, J; Voigt, N; Abu-Taha, IH; Dobrev, D.
Rhythm Control of Atrial Fibrillation in Heart Failure
HEART FAIL CLIN. 2013; 9(4): 407-+.
Doi: 10.1016/j.hfc.2013.06.001
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Heijman Jordi
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Atrial fibrillation (AF) and heart failure (HF) are common cardiovascular pathologies with severe prognostic implications that show bidirectional interactions. Rate and rhythm control are the main therapeutic strategies for patients with AF and HF. There is a paucity of safe and effective antiarrhythmic drugs for rhythm control of AF in HF, with amiodarone and (in the United States) dofetilide as the only imperfect options. The basic mechanisms of AF are discussed and the evidence and limitations of AF rhythm control options for patients with HF are reviewed. In addition, novel potential antiarrhythmic strategies for rhythm control of AF are highlighted.
- Find related publications in this database (Keywords)
- Antiarrhythmic drugs
- Atrial fibrillation
- Heart failure
- Rhythm control